ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia.

Alba Matas-Céspedes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.